GSAC — Gelstat Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Gelstat, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2013 December 31st	2014 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.016	1.31	0.004	0.007	0.002
Cost of Revenue
Gross Profit	0.003	0.222	0.003	0.004	0.001
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	0.426	2.61	0.179	0.252	0.598
Operating Profit	-0.41	-1.3	-0.176	-0.245	-0.596
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.407	-1.3	-0.178	-0.475	-0.761
Provision for Income Taxes
Net Income After Taxes	-0.407	-1.3	-0.178	-0.475	-0.761
Net Income Before Extraordinary Items
Net Income	-0.407	-1.3	-0.178	-0.475	-0.761
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.407	-1.3	-0.178	-0.475	-0.761
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.003	-0.004	-0	-0.001	-0.001
Dividends per Share